Real-time Analysis of Skin Biopsy Specimens With 2-Photon Fluorescence Microscopy.
Vincent D Ching-Roa, Chi Z Huang, Sherrif F Ibrahim...
https://pubmed.ncbi.nlm.nih.gov/36069886/Actively Recruiting
Led by University of Rochester · Updated on 2025-03-17
52
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying basal cell carcinoma, a type of skin cancer, to evaluate the use of two photon fluorescence microscopy TPFM in detecting residual cancer during standard local excision surgery. The goal is to compare TPFM imaging results with the current standard method of examining surgical margins using permanent tissue sections to confirm if cancer has been fully removed. The study involves imaging excised tissue samples with TPFM to measure the distance from the tumor to the nearest inked surgical margin. After TPFM imaging, the tissue will undergo the usual histological processing with paraffin embedding and slide scanning for margin assessment. Researchers will compare the measurements from the TPFM images to the standard permanent section results to determine how well the new imaging method agrees with conventional pathology. Participants will have their excised tissue imaged with TPFM before it is processed with the standard histology methods. Researchers will collect and analyze data on the agreement between TPFM and permanent sections regarding margin distance and margin status. The primary outcome measure is the quantitative agreement between margin distances measured by TPFM and conventional histology, typically assessed 2 to 4 weeks after surgery. This study does not involve any masking or randomization and will monitor the accuracy of TPFM imaging in this clinical context.
CONDITIONS
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
M
Michael Giacomelli, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Rochester
Lead Sponsor
Rochester Dermatologic Surgery
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | TPFM Imaging of Surgical Margins (Investigational) | Histopathology (Current Standard) |
|---|---|---|
| What is it? | A real-time imaging technique that uses two photon fluorescence microscopy to examine the margins of excised tissue removed during surgery for basal cell carcinoma, performed before standard histological processing. | The current gold standard diagnostic approach, using paraffin-embedded histopathology to assess whether cancerous cells are present at the excision margins after surgery. |
| Role in the trial | Investigational imaging method being evaluated for agreement with standard histopathology in margin status assessment. | Serves as the clinical reference standard for confirming whether resection margins are clear of cancer. |
| Primary use | Intended for rapid, intraoperative visualization of surgical margins to potentially improve identification of residual tumor during basal cell carcinoma removal. | Used for definitive assessment of excision margins to determine if further surgery is needed. |
| How is it given or performed? | Excised tissue margins are analyzed using two photon fluorescence microscopy in the operating room prior to routine processing for histological examination. | Excised tissue is fixed, embedded in paraffin, sectioned, stained, and assessed by a pathologist to establish margin status. |
| Evidence status | Currently under study to determine accuracy and agreement with histopathology for margin status; limited clinical validation available. | Extensive clinical validation as the gold standard for margin status in skin cancer surgery. |
| Important limitations | Not yet proven to replace histopathology; accuracy, workflow impact, and clinical outcome benefits still require validation in larger trials. | Turnaround time for margin results is typically several days, potentially delaying decision-making about residual tumor. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Participants undergo surgical excision of basal cell carcinoma with tissue removed for imaging and histological analysis.
1 surgical visit (in-person)
Duration - Same day as surgery
Excised tissue is imaged using two photon fluorescence microscopy (TPFM) to evaluate the distance from tumor to the nearest inked margin before standard histological processing.
1 imaging visit (in-person)
Duration - 2 to 4 weeks post surgery
Standard of care permanent sections are processed and analyzed to confirm surgical margins and compare with TPFM imaging results.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Vincent D Ching-Roa, Chi Z Huang, Sherrif F Ibrahim...
https://pubmed.ncbi.nlm.nih.gov/36069886/University of Rochester
Lead Sponsor
Rochester Dermatologic Surgery
Collaborating Sponsor